Ischemia is a known stimulus for vascular growth. Bone marrow (BM)–derived endothelial
progenitor cells (EPCs) are believed to contribute to new blood vessel growth, but the …

Objective—Bone marrow-derived progenitor cells have been implicated to contribute to
neointima formation, but the time course and extent of their accumulation and differentiation …

Bone marrow-Derived cells have been proposed to form new vessels or at least incorporate
into growing vessels in adult organisms under certain physiological and pathological …

Recent studies indicate that portions of ischemic and tumor neovasculature are derived by
neovasculogenesis, whereby bone marrow (BM)–derived circulating endothelial progenitor …

Background—Endothelial progenitor cells (EPCs) have been identified in adult human
peripheral blood. Because circulating EPCs should originate from bone marrow (BM), we …

OBJECTIVE: Vasculogenesis relies on the recruitment of bone marrow-derived endothelial
progenitor cells (BMD EPCs) and is stimulated by tissue-level ischemia. We hypothesized …

Proper formation of blood vessels (angiogenesis) is essential for development, reproduction
and wound healing. When derailed, angiogenesis contributes to numerous lifethreatening …

Bone marrow–derived cells (BMCs) have been implicated as a modifiers of vascular growth
either directly by transdifferentiation into endothelial cells (ECs) or indirectly through growth …

Cell-based therapy has emerged as a promising therapeutic tool for treatment of ischemic
cardiovascular disease. Both unselected bone marrow-derived mononuclear cells (BMNCs) …

Bone marrow (BM)-derived cells are thought to participate in the growth of blood vessels
during postnatal vascular regeneration and tumor growth, a process previously attributed to …